Triple Analysis: Lung Cancer, Pancreatic Cancer and Protein Kinase InhibitorsBioSeeker Group ABMay 1, 2012 5366 Pages - SKU: BIOS3874025 |
|
The World Market for Pain Management Drugs and Devices
5/20/2013 | published by: Kalorama Information
The World Market for Pain Management Drugs and Devices encompasses a wide variety of products that treat and ease pain. The field of pain management is currently experiencing a busy and interesting period; and
|
read more...
|
$3,500.00
|
|
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
5/8/2013 | published by: Kalorama Information
The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis,
|
read more...
|
$4,500.00
|
|
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players
5/15/2013 | published by: GlobalData
PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Chronic Myeloid Leukemia (CML) - Current and Future Players”. The report is a vital source of up-to-date information with
|
read more...
|
$2,995.00
|
|
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Gleevec (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
|
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Sprycel (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
|
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tasigna (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
|
Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Bosulif (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
|
Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Iclusig (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
|
Lymphoma Treatment Drugs Markets in China
5/1/2013 | published by: Asia Market Information & Development Company
China's demand for lymphoma treatment drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic
|
read more...
|
$2,000.00
|
|
Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022
5/15/2013 | published by: GlobalData
Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Synribo (Chronic Myeloid Leukemia) - Forecast and Market Analysis to 2022”. Chronic myeloid leukemia (CML) is
|
read more...
|
$3,495.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Oncology/Hematology Reports